Search research articles
Contact Us
Filters
Showing results (1-10 of 82) with videos related to
Page
of 9
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
July 2, 2022
Correction to: The FIDELIO Study Podcast
Robert Toto, George Bakris
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 24, 2022
The FIDELIO Study Podcast
Robert Toto, George Bakris
NDT Plus
|
May 23, 2009
Future perspectives on treatment with erythropoiesis-stimulating agents in high-risk patients
Stefan D Anker, Robert Toto
American Journal of Nephrology
|
December 13, 2007
Rationale for combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor treatment and end-organ protection in patients with chronic kidney disease
Robert Toto, Biff F Palmer
American Journal of Hypertension
|
August 8, 2009
Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination
Andrew S Bomback, Robert Toto
Lancet (London, England)
|
January 16, 2007
Living kidney donation and hypertension risk
Thai Nguyen, Miguel Vazquez, Robert Toto
Advances in Chronic Kidney Disease
|
January 13, 2011
Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management
Peter N Van Buren, Robert Toto
Current Diabetes Reviews
|
November 22, 2012
Current update in the management of diabetic nephropathy
Peter Noel Van Buren, Robert Toto
Hypertension (Dallas, Tex. : 1979)
|
November 5, 2014
Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases
Johann Bauersachs, Frédéric Jaisser, Robert Toto
Journal of Clinical Hypertension (Greenwich, Conn.)
|
June 9, 2011
Identification and management of albuminuria in the primary care setting
Louis Kuritzky, Robert Toto, Peter Van Buren
Page
of 9
Search research articles
Search
Showing results (1-10 of 82) with videos related to
Sort By:
Page
of 9
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
July 2, 2022
Correction to: The FIDELIO Study Podcast
Robert Toto, George Bakris
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 24, 2022
The FIDELIO Study Podcast
Robert Toto, George Bakris
NDT Plus
|
May 23, 2009
Future perspectives on treatment with erythropoiesis-stimulating agents in high-risk patients
Stefan D Anker, Robert Toto
American Journal of Nephrology
|
December 13, 2007
Rationale for combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor treatment and end-organ protection in patients with chronic kidney disease
Robert Toto, Biff F Palmer
American Journal of Hypertension
|
August 8, 2009
Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination
Andrew S Bomback, Robert Toto
Lancet (London, England)
|
January 16, 2007
Living kidney donation and hypertension risk
Thai Nguyen, Miguel Vazquez, Robert Toto
Advances in Chronic Kidney Disease
|
January 13, 2011
Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management
Peter N Van Buren, Robert Toto
Current Diabetes Reviews
|
November 22, 2012
Current update in the management of diabetic nephropathy
Peter Noel Van Buren, Robert Toto
Hypertension (Dallas, Tex. : 1979)
|
November 5, 2014
Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases
Johann Bauersachs, Frédéric Jaisser, Robert Toto
Journal of Clinical Hypertension (Greenwich, Conn.)
|
June 9, 2011
Identification and management of albuminuria in the primary care setting
Louis Kuritzky, Robert Toto, Peter Van Buren
Page
of 9